---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-24-029301"
form_type: "8-K"
ticker: "CCCC"
cik: "0001662579"
company_name: "C4 Therapeutics, Inc."
filed_at: "2024-06-21T23:59:59+00:00"
generated_at: "2026-06-01T02:52:38.488266+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# C4 Therapeutics stockholders elect three Class I directors, approve say-on-pay, ratify KPMG

## Summary
- Kenneth Anderson re-elected with 38.0M for, 8.6M withheld; Laura Bessen with 37.7M for, 8.8M withheld; Owen Hughes with 27.5M for, 19.1M withheld.
- Advisory say-on-pay passed: 34.5M for, 11.9M against, 0.1M abstain.
- KPMG LLP ratified as independent auditor for FY2024: 54.4M for, 0.2M against, 0 abstain.
- No other matters were voted on at the annual meeting.

## SEC filing metadata
- accession: 0001628280-24-029301
- form_type: 8-K
- ticker: CCCC
- cik: 0001662579
- company_name: C4 Therapeutics, Inc.
- filed_at: 2024-06-21T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1662579/000162828024029301/0001628280-24-029301-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1662579/000162828024029301/cccc-20240621.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-24-029301
- JSON: https://secwatch.observer/filing/0001628280-24-029301.json
- Plain text: https://secwatch.observer/filing/0001628280-24-029301.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.